GF48449391
Iron
rod, 1000mm, diameter 12.7mm, as drawn, 98+%
Synonym(s):
Iron, FE007957
Sign Into View Organizational & Contract Pricing
All Photos(2)
About This Item
Linear Formula:
Fe
CAS Number:
Molecular Weight:
55.85
MDL number:
UNSPSC Code:
12141721
PubChem Substance ID:
NACRES:
NA.23
Assay
98%
form
rod
manufacturer/tradename
Goodfellow 484-493-91
resistivity
9.71 μΩ-cm
L × diam.
1000 mm × 12.7 mm
bp
2750 °C (lit.)
mp
1535 °C (lit.)
density
7.86 g/mL at 25 °C (lit.)
SMILES string
[Fe]
InChI
1S/Fe
InChI key
XEEYBQQBJWHFJM-UHFFFAOYSA-N
General description
For updated SDS information please visit www.goodfellow.com.
Legal Information
Product of Goodfellow
Choose from one of the most recent versions:
Certificates of Analysis (COA)
Lot/Batch Number
Sorry, we don't have COAs for this product available online at this time.
If you need assistance, please contact Customer Support.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Catherine F M Bowden et al.
Biochemistry, 53(14), 2286-2294 (2014-03-22)
The Isd (iron-regulated surface determinant) system is a multiprotein transporter that allows bacterium Staphylococcus aureus to take up iron from hemoglobin (Hb) during human infection. In this system, IsdB is a cell wall-anchored surface protein that contains two near iron
Antonino Missineo et al.
Infection and immunity, 82(6), 2448-2459 (2014-04-02)
Staphylococcus lugdunensis is a coagulase-negative staphylococcus that is a commensal of humans and an opportunistic pathogen. It can cause a spectrum of infections, including those that are associated with the ability to form biofilm, such as occurs with endocarditis or
Florence Lima et al.
Environmental and molecular mutagenesis, 55(3), 266-277 (2014-04-12)
DNA methylation is an epigenetic mechanism that drives phenotype and that can be altered by environmental exposures including radiation. The majority of human radiation exposures occur in a relatively low dose range; however, the biological response to low dose radiation
Maria Wilhelm et al.
Clinical nephrology, 81(4), 251-258 (2014-03-25)
Hyperphosphatemia in advanced chronic kidney disease (CKD) necessitates the use of phosphate binders. This in vitro study assessed phosphate binding and Fe release properties of the novel iron-based phosphate binder PA21. Phosphate adsorption and Fe release were assessed under conditions
S J Ford et al.
Annals of the Royal College of Surgeons of England, 96(4), 275-278 (2014-05-02)
The incidence of oesophageal adenocarcinoma (OAC) is rising dramatically and overall survival remains extremely poor. Iron has been shown to potentiate tumourigenesis in OAC, and iron chelation therapy demonstrates promise in vivo as an adjunct to neoadjuvant and palliative chemotherapy.
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service